Original Research
2021 Jan 13.
JOURNAL：Circulation.
Article Link
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial
GG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
KEYWORDS
PCSK9 inhibition; lipoprotein(a)
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
